Other GLP-1 receptor agonists combining retatrutide with another GLP-1 RA is not recommended, as this is not supported by clinical evidence and may increase the risk of adverse effects
Med Princ Pract 29(4):364370
[DOI] [PMC free article] [PubMed] [Google Scholar] 52.Carro E, Trejo JL, Gomez-Isla T, LeRoith D, and Torres-Aleman I
If a pregnant patient has a documented deficiency of one or more B vitamins or a condition like hyperemesis that prevents oral intake, the benefits of correcting the deficiency (preventing serious maternal and fetal complications) outweigh any minimal risk from the injection
Additionally, BPC-157 has been shown to enhance the bodys antioxidant defenses by increasing levels of superoxide dismutase (SOD), one of the main intracellular antioxidants that protect cells from reactive oxygen species (ROS)
Manufactured for laboratory research